Semi-Annual Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7712791

Concept 2018-06-01 to
2019-02-28
2017-06-01 to
2018-02-28
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
3,665,617,000 JPY
3,185,330,000 JPY
Non-operating income
Non-operating income
111,591,000 JPY
95,008,000 JPY
Non-operating expenses
Non-operating expenses
24,199,000 JPY
34,951,000 JPY
Ordinary profit (loss)
3,753,009,000 JPY
3,245,387,000 JPY
Extraordinary income
Extraordinary income
194,928,000 JPY
20,524,000 JPY
Extraordinary losses
Extraordinary losses
184,092,000 JPY
525,000 JPY
Profit (loss) before income taxes
3,763,845,000 JPY
3,265,386,000 JPY
Profit (loss)
2,539,069,000 JPY
2,280,208,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.